Celltrion is rolling out an HIV treatment in the U.S.

Home > Business > Industry

print dictionary print

Celltrion is rolling out an HIV treatment in the U.S.

Celltrion said Tuesday that it is introducing Temixys, an HIV treatment, in the coming weeks to the United States. It is the first branded product from the company.

The Korean biopharmaceutical company’s U.S. affiliate will be tasked with distributing and promoting market access for the treatment. The U.S. Food and Drug Administration approved the drug in November last year.

Celltrion USA held its first seminar for HIV physicians in New York last month to promote the drug and educate treatment guidelines. It is launching a Temixys-dedicated mobile application with information on the medicine for HIV-positive patients and medical professionals.

By Ko Jun-tae

More in Industry

No dial tone for 2G services on LG U+ starting in June

Ironing out an air corridor took decades

Kia reinvents itself, promising 'movement that inspires'

Hanwha Energy teams up with France's Total in U.S.

Scatter Lab investigated, but not for odd messages

Log in to Twitter or Facebook account to connect
with the Korea JoongAng Daily
help-image Social comment?
lock icon

To write comments, please log in to one of the accounts.

Standards Board Policy (0/250자)

What’s Popular Now